Diabetic patients suffering dengue are at risk for development of dengue shock syndrome/severe dengue: Emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Ing-Kit LeeJien-Wei Liu

Abstract

The impact of type 2 diabetes mellitus (DM2) on clinical severity of dengue has not been fully understood. We aimed to assess risk factors for dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) and severe dengue (SD) (defined based on the World Health Organization 1997 and 2009 dengue classifications), and additionally identify, among DM2 patients, who are at risk for developing DHF/DSS and severe dengue. A retrospective analysis of dengue patients diagnosed between 2002 and 2010. Risk factors for development of DHF/DSS/SD were identified using multivariate analysis. To elucidate the impacts of coexisting comorbidity(ies) (i.e., hypertension, chronic kidney disease, old stroke, and/or ischemic heart disease) and glycemic control on clinical outcomes of dengue in DM2 patients, the overall DM2 patients and stratified DM2 patients (HbA1c < 7% vs. HbA1c ≧ 7%), with or without comorbidity(ies), were separately compared to controls (patients without any morbidity). Of 767 (146 DM2 and 621 controls) included patients, 1.4% suffered DSS and 3.3% SD. While DM2 was an independent risk factor for DSS (adjusted odds ratio [AOR] = 7.473; 95% confidence interval [CI] = 2.221-25.146) and SD (AOR = 6.207; 95% CI = 2.464-15.636), only D...Continue Reading

Citations

Oct 10, 2018·The American Journal of Tropical Medicine and Hygiene·Gabriela Salmón-MulanovichWilliam K Pan
Sep 25, 2019·International Journal of Molecular Sciences·Madiiha Bibi MandaryChit Laa Poh
Oct 15, 2019·Journal of Travel Medicine·Lidia Redondo-BravoZaida Herrador
Jul 5, 2018·BMC Research Notes·Ramawatar Prasad KhetanBirendra Prasad Gupta
Jan 24, 2020·Expert Review of Anti-infective Therapy·Po Ying ChiaYee Sin Leo
Nov 17, 2020·Frontiers in Cellular and Infection Microbiology·Gathsaurie Neelika MalavigeGraham S Ogg
Nov 20, 2020·Tropical Medicine and Infectious Disease·N L Ajantha ShyamaliGathsaurie Neelika Malavige
Apr 9, 2020·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wen-Hung WangSheng-Fan Wang
Apr 13, 2021·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ko ChangYen-Hsu Chen
Aug 4, 2021·BMC Infectious Diseases·Tsheten TshetenKinley Wangdi
Oct 11, 2021·Infectious Diseases of Poverty·Tsheten TshetenKinley Wangdi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Journal of Infection in Developing Countries
Prashant GuptaTapan Kumar Nirod Chandra Dhole
Indian Journal of Pediatrics
L KabilanK Satyanarayana
The Journal of Infectious Diseases
Catherine A LaughlinAnthony S Fauci
International Journal of Medical Sciences
Zuleeza Ahmad, Chit Laa Poh
© 2022 Meta ULC. All rights reserved